Related Experiment Video
Updated: Feb 1, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation
Christina Guzzo1, Peng Zhang1, Qingbo Liu1
1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Two conserved tyrosines in the HIV-1 envelope protein maintain a closed structure, shielding the virus from antibodies. Mutations reveal these tyrosines are crucial for HIV-1 immune evasion, impacting vaccine development.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) evades immune detection through its envelope (Env) trimer, which adopts a closed conformation.
- Understanding HIV-1 immune evasion mechanisms is critical for developing effective vaccines.
Purpose of the Study:
- To identify key structural elements responsible for maintaining the closed, antibody-resistant state of the HIV-1 Env trimer.
- To investigate the role of conserved tyrosines in the V2 loop of gp120 in HIV-1 immune evasion.
Main Methods:
- Site-directed mutagenesis of conserved tyrosines (Y173, Y177) in the gp120 V2 loop.
- Assessment of HIV-1 neutralization sensitivity to various antibodies.
- Analysis of antibody responses in HIV-1 infected patient sera.
Main Results:
- Mutations in V2 loop tyrosines (Y173, Y177) destabilized the Env trimer, increasing susceptibility to non-neutralizing antibodies.
- Broadly neutralizing antibodies (bNAbs) showed reduced efficacy against V2 loop tyrosine mutants.
- HIV-1 infected individuals' sera contained antibodies effective against open Env forms but not the native, closed trimer.
Conclusions:
- A tyrosine-mediated V2-V3 loop complex at the Env trimer apex is essential for HIV-1 evasion from host antibodies.
- The closed Env conformation shields conserved vulnerable sites, limiting antibody accessibility.
- Targeting this structural constraint could inform novel HIV-1 vaccine strategies.
More Related Videos
07:29Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
Published on: December 1, 2011
11:45Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers
Published on: March 8, 2012
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Stability of structures
Conformity
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Constraints and Statical Determinacy
Viral Structure